バイオサージェリーの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

バイオサージェリーの市場規模は2022年に145億6,000万米ドルと評価され、2023年の155億6,000万米ドルから2031年には265億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは6.9%で成長する見通しです。

バイオサージェリーの世界市場は、手術方法の進歩や低侵襲手術への嗜好の高まりによって、顕著な成長を遂げています。バイオサージェリーは、止血剤、シーラント、軟組織修復製品などの生物学的材料の使用を包含し、治癒プロセスの強化や手術結果の改善を支援します。この市場の拡大には、手術件数の増加、慢性疾患の罹患率の上昇、高齢者人口の増加など、いくつかの要因が寄与しています。さらに、個別化医療の動向や革新的な生物学的製剤の市場開拓が、市場成長の加速に重要な役割を果たしています。しかし、厳しい規制基準やバイオサージェリー製品に関連する高コストが、より広い普及を妨げる可能性があるため、市場は課題に直面しています。このような障害にもかかわらず、世界のバイオサージェリー市場は、先進的な外科手術技術の創造と商業化に注力する企業にとって大きなビジネスチャンスを提供しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制分析
• サプライチェーン分析

バイオサージェリー市場：製品別

• 市場概要
• 骨移植代替品
  • 脱灰骨基質
  • 人工骨移植
  • 骨形成タンパク質
  • その他の骨移植代替品
• 軟部組織付着部
  • 合成メッシュ
  • 生物学的メッシュ
  • 同種移植
  • 異種移植
• 止血剤
  • トロンビン系止血剤
  • 酸化再生セルロース系止血剤
  • 複合止血剤
• 外科手術用シーラントおよび接着剤
  • 天然/生物由来のシーラントと接着剤
  • タイプ別
  • フィブリンベースのシーラントおよび接着剤
  • コラーゲンベースのシーラントと接着剤
  • ゼラチンベースのシーラントおよび接着剤
  • アルブミンベースのシーラント
  • その他の天然/生物由来のシーラントおよび接着剤
  • 起源別
  • 動物由来のシーラントと接着剤
  • ヒト血液ベースのシーラントおよび接着剤
  • 合成および半合成シーラントおよび接着剤
  • PEGハイドロゲルベースのシーラントおよび接着剤
  • シアノアクリレート系シーラントおよび接着剤
  • ウレタン系シーラントおよび接着剤
  • その他の合成および半合成シーラントおよび接着剤
• 癒着防止バリア
  • 合成癒着防止材
  • ヒアルロン酸ベースの癒着防止材
  • 再生セルロースベースの癒着防止材
  • ペグベースの癒着防止材
  • その他の合成癒着防止剤
  • 天然癒着防止バリア
  • コラーゲンとタンパク質の接着バリア
  • フィブリンベースの癒着防止材
• ステープルライン補強剤

バイオサージェリー市場：用途別

• 市場概要
• 整形外科手術
• 一般外科手術
• 神経外科手術
• 心臓血管外科手術
• 再建手術
• 婦人科手術
• 泌尿器科手術
• 胸部手術
• その他の用途

バイオサージェリー市場：エンドユーザー別

• 市場概要
• 病院
• クリニック
• その他のエンドユーザー

バイオサージェリー市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Baxter International Inc.（US）
• B. Braun Melsungen AG（Germany）
• Becton, Dickinson & Company（US）
• Johnson & Johnson（US）
• Medtronic Plc（Ireland）
• Integra Lifesciences Holdings Corporation（US）
• Commonwealth Serum Laboratories Limited（Australia）
• Hemostasis LLC（US）
• Pfizer Inc.（US）
• Stryker Corporation（US）
• Zimmer Biomet（US）
• Kuros Biosciences AG（Switzerland）
• Orthofix Medical Inc.（US）
• Smith & Nephew Plc（UK）
• Tissue Regenix Group Plc（UK）
• Betatech Medical（Turkey）
• Meril Life Sciences Pvt. Ltd.（India）
• Samyang Holdings Corporation（South Korea）
• Aroa Biosurgery Ltd.（New Zealand）
• Meyer-Haake Gmbh（Germany）
• Biom Up（France）
• Biocer Entwicklungs-Gmbh（Germany）
• Hannox International Corp.（Taiwan）

Biosurgery Market size was valued at USD 14.56 billion in 2022 and is poised to grow from USD 15.56 billion in 2023 to USD 26.54 billion by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).

The global biosurgery market is undergoing notable growth, driven by advancements in surgical methods and the rising preference for minimally invasive procedures. Biosurgery encompasses the use of biological materials like hemostatic agents, sealants, and soft tissue repair products, which aid in enhancing the healing process and improving surgical results. Several factors are contributing to the expansion of this market, including the increasing number of surgeries, the rising incidence of chronic diseases, and the growing elderly population. Additionally, the trend toward personalized medicine and the development of innovative biologic products are playing a key role in accelerating market growth. However, the market faces challenges due to stringent regulatory standards and the high costs associated with biosurgery products, which may hinder wider adoption. Despite these obstacles, the global biosurgery market offers significant opportunities for companies focused on creating and commercializing advanced surgical technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosurgery Market Segmental Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Biosurgery Market

A major factor fueling the growth of the global biosurgery market is the rising demand for minimally invasive surgical procedures. These products are commonly used in such surgeries due to their ability to reduce trauma, speed up recovery, and minimize scarring. As patients and surgeons increasingly favor less invasive techniques, the demand for biosurgery solutions continues to rise. Moreover, technological advancements, including the development of cutting-edge biomaterials and surgical sealants, are accelerating the market's expansion. These innovations are enhancing the effectiveness of biosurgery products, further boosting their adoption in various surgical applications.

Restraints in the Global Biosurgery Market

A significant challenge for the global biosurgery market is the strict regulatory requirements and prolonged approval processes for new products. Biosurgery products must undergo extensive testing, clinical trials, and meet stringent safety and efficacy standards. These regulatory demands can lead to delays in bringing new products to market and inflate development costs. Additionally, the complex regulatory environment can hinder manufacturers' ability to innovate and launch new offerings. The high costs of regulatory compliance and product development often create entry barriers, particularly for small and medium-sized companies, limiting their participation and slowing overall market growth.

Market Trends of the Global Biosurgery Market

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. These techniques provide multiple benefits compared to traditional open surgeries, such as smaller incisions, less scarring, quicker recovery, and fewer postoperative complications. Consequently, there is growing demand for biosurgical products tailored specifically for minimally invasive procedures. This trend is fueled by the rising preference among patients and healthcare providers for less invasive treatments that deliver comparable or improved outcomes. In response, manufacturers in the biosurgery market are focusing on developing innovative products and techniques to meet this demand and improve patient satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Supply Chain Analysis

Biosurgery Market by Product

• Market Overview
• Bone-Graft Substitutes
  • Demineralized Bone Matrix
  • Synthetic Bone Grafts
  • Bone Morphogenetic Proteins
  • Other Bone-Graft Substitutes
• Soft-Tissue Attachments
  • Synthetic Meshes
  • Biological Meshes
  • Allografts
  • Xenografts
• Hemostatic Agents
  • Thrombin-Based Hemostatic Agents
  • Oxidized Regenerated Cellulose-Based Hemostatic Agents
  • Combination Hemostatic Agents
• Surgical Sealants & Adhesives
  • Natural/Biological Sealants & Adhesives
  • By Type
  • Fibrin-Based Sealants & Adhesives
  • Collagen-Based Sealants & Adhesives
  • Gelatin-Based Sealants & Adhesives
  • Albumin-Based Sealants
  • Other Natural/Biological Sealants & Adhesives
  • By Origin
  • Animal-Based Sealants & Adhesives
  • Human Blood-Based Sealants & Adhesives
  • Synthetic And Semi-Synthetic Sealants & Adhesives
  • PEG Hydrogel-Based Sealants & Adhesives
  • Cyanoacrylate-Based Sealants & Adhesives
  • Urethane-Based Sealants & Adhesives
  • Other Synthetic And Semi-Synthetic Sealants & Adhesives
• Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Hyaluronic Acid-Based Adhesion Barriers
  • Regenerated Cellulose-Based Adhesion Barriers
  • Peg-Based Adhesion Barriers
  • Other Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
  • Collagen And Protein Adhesion Barriers
  • Fibrin-Based Adhesion Barriers
• Staple-Line Reinforcement Agents

Biosurgery Market by Application

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Other Applications

Biosurgery Market by End User

• Market Overview
• Hospitals
• Clinics
• Other End Users

Biosurgery Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Commonwealth Serum Laboratories Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Betatech Medical (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Holdings Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meyer-Haake Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom Up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocer Entwicklungs-Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hannox International Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments